Common risk factors for major noncommunicable disease,a systematic overview of reviews and commentary: the implied potential for targeted risk reduction

Abstract

Noncommunicable disease now contributes to the World Health Organization top 10 causes of death in low-, middle- and high-income countries. Particular examples include stroke, coronary heart disease, dementia and certain cancers. Research linking clinical and lifestyle risk factors to increased risk of noncommunicable disease is now well established with examples of confirmed risk factors, including smoking, physical inactivity, obesity and hypertension. However, despite a need to target our resources to achieve risk reduction, relatively little work has examined the overlap between the risk factors for these main noncommunicable diseases. Our high-level review draws together the evidence in this area. Using a systematic overview of reviews, we demonstrate the likely commonality of established risk factors having an impact on multiple noncommunicable disease outcomes. For example, systematic reviews of the evidence on physical inactivity and poor diet found each to be associated with increased risk of cancers, coronary heart disease, stroke, diabetes mellitus and dementia. We highlight the potential for targeted risk reduction to simultaneously impact multiple noncommunicable disease areas. These relationships now need to be further quantified to allow the most effective development of public health interventions in this area.

Keywords

non-communicable disease dementia heart disease cancer diabetes hypertension obesity physical activity hyperten air pollution

Introduction

A world with inevitably limited resources requires prioritization of those resources and the arena of public health is no exception. As the world faces unprecedented numbers of older adults and levels of noncommunicable disease (NCD),¹ there has been an increased orientation towards strategies for risk reduction, NCD prevention² and effective ways to support healthy ageing.³ The most recent NCD area to rise to prominence, partly due to our ageing population, is dementia.⁴ The last 20–30 years has seen an exponential rise in research on the identification and understanding of dementia risk factors. This began with investigation of single risk factors, for example,^5–7 clinical trials^8–10 and evidence synthesis,^11–13 most recently moving towards a developing understanding of the impact of multiple co-occurring risk factors¹⁴ and multifactorial risk reduction.^15–17

In 2016, dementia also appeared for the first time as one of five NCDs ranked in the World Health Organization (WHO) top 10 causes of death globally alongside other NCD categories, coronary heart disease (CHD), stroke, diabetes mellitus (DM) and cancers.¹⁸ When evaluated across lower-, middle- and high-income economies, CHD and stroke maintain their places consistently within the top five causes of death and top causes of NCD-related death. DM is present in all but the lowest income category and dementia is within the top five causes of death in upper-middle- and high-income countries. Amongst the cancers, trachea, bronchus and lung, liver and stomach, colon and rectum and breast cancers also ranked within the top 10 causes of death in upper-middle- and high-income countries in 2016.¹⁸ Importantly, dementia and other NCDs, such as CHD, share more than their ranking in the WHO top 10 causes of death. They are also characterized by multiple overlapping lifestyle and clinical risk factors (for example, obesity, physical inactivity, high blood pressure), acting singly or together to increase risk, and may all benefit from risk reduction efforts.^19–22 Depression, diabetes or impaired glucose tolerance, high cholesterol, high blood pressure, obesity, unhealthy diet, smoking, physical inactivity and excess alcohol consumption have been identified by the WHO Global Health Observatory data as common and preventable risk factors that underlie most NCDs.²³ Increasing evidence also points to air pollution as an emerging risk factor for dementia, heart and cardiovascular disease and lung cancer.^1,14

To more accurately model the influence of risk factor prevalence and risk factor modification on incident disease and health outcomes, and to effectively target risk reduction strategies, we now need to understand the overlap between risk factors and the main NCDs. The aim of this systematic overview of reviews was to identify and evaluate the evidence for overlapping risk factors between dementia, DM, CHD, stroke and selected cancers.

Methods

We completed a detailed systematic overview of reviews.²⁴ That is, we reviewed published overviews and reviews reporting on one or more common risk factors and one or more of the NCD categories, dementia, DM, CHD, stroke and selected cancers. A written protocol was registered with the International Prospective Register of Systematic Reviews (PROSPERO; CRD42019129265) and the review was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist.²⁵

The Cochrane Database of Systematic Reviews, and Ovid MEDLINE were searched from inception to 1 March 2019. The following NCD keywords were used: dementia, Alzheimer’s (or Alzheimer or Alzheimers) disease, diabetes, ischaemic (or ischemic) heart disease, coronary artery disease, coronary heart disease, myocardial infarction, stroke, cancer, together with the following keywords for the nine common risk factors: depression, cholesterol, hypertension, obesity, diet, smoking, physical activity, alcohol or air pollution. Supplementary text file 1 provides full details of the search terms. Additional data sources included a review of guidelines published by the WHO, the UK National Institute for Health and Care Excellence, systematic reviews commissioned by the Agency for Healthcare Research and Quality and expert recommendation.

Given the volume of data in this area and the need to include the most up-to-date evidence synthesis, we used a pragmatic selection method, adapted from guideline development methodology, selecting the most comprehensive and recent evidence sources.²⁶ To achieve this we selected published overviews or reviews (sometimes referred to as umbrella reviews) or, where these were unavailable, single systematic reviews. We selected the most recently published review in each area first examining those published within the last 5 years and only looking at earlier literature where recent publications were not available. If two publications were available from the same year, the publication with the most recent search dates was used. Reviews were required to report meta-analyses of prospective studies reporting an association between one or more of the nine selected risk factors and one or more of the selected incident NCDs. Established and prevalent risk factors were selected (based on those recognized by the WHO www.who.int/healthinfo/global_burden_disease/global_health_risks/en) to include depression, high cholesterol, high blood pressure, obesity, diet (whole dietary pattern), smoking, physical inactivity, excess alcohol consumption or air pollution). The NCDs included: dementia [all-cause or Alzheimer’s disease (AD) or vascular dementia (VaD)], DM, CHD (defined as coronary artery disease, ischaemic heart disease or myocardial infarction), stroke (ischaemic or haemorrhagic) or cancer (of all types or of the lung, liver, bowel or breast in accordance with the cancer types featured in the WHO top 10 causes of death).¹⁸ Meta-analyses of prospective longitudinal cohort studies were selected to provide the most robust information on relationships between risk factor exposure and disease development. Cross-sectional and case-control studies were excluded because they do not provide sufficiently robust data with regard to the evaluation of causality between risk factors and disease outcomes. Furthermore, clinical trials were not included, as the focus of this research was on the relationship between risk factors and disease rather than on risk reduction. We also excluded nonsystematic reviews, narrative reviews, reviews focusing solely on dietary constituents, as opposed to whole diet and reviews including studies conducted in secondary prevention populations (i.e. in populations that already have one of the five selected NCD outcomes). The varied source data also meant that it was not possible to statistically synthesize the data nor to fully take subgroups, such as the age of risk factor exposure, into account; however, where differing results were reported from broad subgroups such as mid/late-life, pre/postmenopausal women, these are reported.

All titles were screened for relevance. Those that were selected as relevant, progressed to abstract screening by two independent reviewers. Disagreement between reviewers was resolved by discussion and further full-text screening took place, with disagreement similarly resolved by discussion. Data extraction was completed by one reviewer and checked by a second independent reviewer. Data on key population and demographic information, risk factor classification, outcome identification and pooled values for the associations between risk factors and outcomes were extracted into an a priori designed extraction table. Reviews were assessed for bias using the revised instrument, AMSTAR-2 (A MeaSurement Tool to Assess systematic Reviews 2) criteria.²⁷

Results

Searching and expert recommendation resulted in 1374 unique records. There were 1173 records rejected at the title screening stage for not reporting results for overview or single systematic reviews relevant to the selected risk factors and NCD categories. The remaining 201 articles were screened at abstract stage, 125 were rejected and 76 were examined at full-text screening (Figure 1). A further 49 articles^{12,13,28–74} were rejected at the full-text stage, primarily due to their relative redundancy given the availability of a more recent review or more current search dates. Overall, nine of these articles^{38,44–47,58,62,63,68} were excluded due to reasons such as nonstandard or inappropriate exposure or outcome measures, data derived from only one cohort study or unclear methodology (Supplementary Table 4 and supplementary reference list), leaving 27 reviews^{11,14,75–99} to be included.

Figure 1.

PRISMA flow chart.

Of the 27 publications selected for inclusion, 5 were overview reviews and 22 were single systematic reviews. All but one review⁷⁸ were published within the last 5 years. From these 27 articles, 89 relevant unique meta-analyses and 1 systematic review, with a figurative rather than statistical forest plot summarizing the data, were examined and extracted (Supplementary Table 1). Overall data on risk factors and dementia, DM, CHD and stroke was reasonably comprehensive. No reviews reported on the relationship between diabetes and cholesterol, diabetes and alcohol, CHD and smoking, stroke and depression, and of the five NCD categories, the least data were available for cancer (Table 1). Table 1 shows the extent of the evidence and the direction of the reported relationships between the risk factors and NCD disease outcomes.

Table 1.

Showing the direction of relationships and extent of the systematic review and meta-analysis evidence for the associations between the selected risk factors and noncommunicable diseases.

		Dietary pattern	Physical activity	Smoking	Air pollution	High blood pressure	Obesity	Depression	High cholesterol	Excess alcohol consumption
Dementia	Any dementia	↓↓ Anstey and colleagues¹¹	↓↓ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	↑↑ PM_2.5 Peters and colleagues¹⁴	.	↑ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹
				↑↑ NO₂, NOx Peters and colleagues¹⁴			≠ Late life Anstey and colleagues¹¹
	AD	↓↓ Anstey and colleagues¹¹	↓↓ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	.	≠ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	↑↑ Mid life Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹
									≠ Late life Anstey and colleagues¹¹
	VaD	.	↓↓ Anstey and colleagues¹¹	↑↑ Anstey and colleagues¹¹	.	↑↑ Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹	≠ Late life Anstey and colleagues¹¹	≠ Anstey and colleagues¹¹
DM		↓↓ Bellou and colleagues⁷⁷	↓↓ Bellou and colleagues⁷⁷	↑↑ Bellou and colleagues⁷⁷	↑↑ Bellou and colleagues⁷⁷	↑↑ Bellou and colleagues⁷⁷	↑↑ Bellou and colleagues⁷⁷	↑↑ Bellou and colleagues⁷⁷	.	.
Stroke		↓↓ Psaltopoulou and colleagues⁹⁰	↓↓ Wahid and colleagues⁹⁴	↑↑ Peters and colleagues⁸⁹	↑↑ Scheers and colleagues⁹²	↑↑ Huang and colleagues⁸⁴	↑↑ Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration and colleagues⁸¹	.	≠ Lindbohm and colleagues⁸⁶	↑↑ Zhang and colleagues⁹⁷
CHD		↓↓ Galbete and colleagues⁹⁸	↓↓ Wahid and colleagues⁹⁴	.	↑↑ PM10 Cesaroni and colleagues⁷⁹	↑↑ Wei and colleagues⁹⁶	↑↑ Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration and colleagues⁸¹	↑↑ Gan and colleagues⁸⁰	↑↑ Peters and colleagues⁸⁸	≠ Roerecke and Rehm⁹¹
					≠ PM_2.5 Cesaroni and colleagues⁷⁹
Cancer	All cancers	↓↓ Galbete and colleagues⁹⁸	↓↓ de Rezende and colleagues⁷⁵	.	.	.	.	.	.	.
	Breast	↓↓ Schwingshackl and colleagues⁹³	↓↓ de Rezende and colleagues⁷⁵	↑↑ Wang and colleagues⁹⁵	.	↑↑ Han and colleagues⁸³	↑↑ Postmenopausal Kygriou and colleagues⁸⁵	.	.	↑↑ Bagnardi and colleagues⁷⁶
							≠ pre-menopausal Kygriou and colleagues⁸⁵
	Bowel	↓↓ Schwingshackl and colleagues⁹³	↓↓ de Rezende and colleagues⁷⁵	↑↑ Botteri and colleagues⁷⁸	.	.	↑↑ Kygriou and colleagues⁸⁵	.	.	↑↑ Bagnardi and colleagues⁷⁶
	Lung	.	↓↓ de Rezende and colleagues⁷⁵	↑↑ O’keeffe and colleagues⁸⁷	↑↑ PM_2.5 Hamra and colleagues⁸²		↓↓ Kygriou and colleagues⁸⁵	.	.	≠ Bagnardi and colleagues⁷⁶
					≠ PM₁₀ Hamra and colleagues⁸²
	Liver	.	.	.	.	.	↑↑ Kygriou and colleagues^83,85	.	.	≠ Turati and colleagues⁹⁹

↑↑, denotes probable positive association; ↓↓, denotes probable negative association; ↑, denotes possible positive association (meta-analyses show mixed but generally positive outcomes); ↓, denotes possible negative association (meta-analyses show mixed but generally negative outcomes); ≠, denotes no association found; ., denotes no review identified.

AD, Alzheimer’s disease; CHD, coronary heart disease; DM, diabetes mellitus; PM, particulate matter.

The most consistent and comprehensive evidence was available for diet and physical activity. High adherence to a Mediterranean diet was shown to reduce risk across all five NCDs by between 4% and 36%,^{11,77,90,93,98} and higher levels of physical activity similarly resulted in risk reduction of between 13% and 45%.^11,75,77,94 The detrimental effects of smoking and obesity were also evident from available data. Smoking was associated with an increased risk of AD, any dementia, VaD, DM, stroke, and lung, bowel and breast cancer with increased risk estimates variously reported between 9% and 633%.^{11,77,78,87,89,95} Obesity was associated with an increased risk of AD, DM, CHD, stroke and liver and bowel cancer by between 33% and 588%.^11,77,81,85 Obesity may also increase the risk of breast cancer in postmenopausal women.⁸⁵ No association was found between obesity and VaD¹¹ and an anomalous protective effect was found for lung cancer that was reported to be derived from a small sample of heterogeneous studies.⁸⁵ High blood pressure was associated with a 7–75% increased risk of VaD, DM, CHD, stroke and breast cancer,^{11,77,83,84,96} but no association was found for AD.¹¹ The evidence for excess alcohol consumption was the least consistent across the NCDs, with three meta-analyses showing significant associations with increased risk and six showing no association. Excess alcohol consumption was associated with an increased risk of stroke, bowel and breast cancer (between 20% and 50%).^11,76,97 However, no association was found between excess alcohol consumption and the dementias,¹¹ CHD,⁹¹ lung⁷⁶ or liver cancer.⁹⁹

Whilst less evidence was available for the remaining risk factors, broad associations were reported between air pollution and an increased risk of dementia,¹⁴ DM,⁷⁷ stroke,⁹² lung cancer⁸² and CHD.⁷⁹ Depression was found to be associated with an increased risk of AD, any dementia, DM and CHD by between 30% and 104%,^11,77,80 but had no effect on VaD risk.¹¹ High cholesterol was associated with a 20–24% increased risk of CHD¹¹ and (when present in midlife) was associated with a doubling in the risk of AD⁸⁸ but had no effect on any dementia, VaD¹¹ or stroke.⁸⁶ Whilst the current data are insufficient to allow the building of a structural equation model, the complexity and overlaps within these relationships can be shown diagrammatically, see Figure 2. Figure 2 also provides additional contextual information, beyond the scope of this review, by highlighting the potential further relationships between the risk factors themselves and between NCD categories. For example, poor diet and lack of physical activity may increase risk of obesity with consequent increased risk of hypertension, and stroke and diabetes are known to raise the risk of later dementia.^100,101

Figure 2.

Diagram showing the reported relationships between established risk factors and NCDs.

Overall, probable or possible associations were observed between all risk factors and at least two of the five NCDs. The strongest protective factors were healthy diet and physical activity, which were shown to impact risk across all five NCDs. Air pollution was linked to all five NCDs with the strongest evidence for fine particle (PM_2.5) exposure. Depression, high blood pressure and obesity were linked to all the NCDs for which there was available data, with some variability amongst dementia and cancer subtype.

Quality rating

The AMSTAR-2 was employed to assess the quality of selected reviews. Of the 27 included publications, 11 (41%) were characterized as critically low quality, 12 (44%) of low quality and 4 (15%) of moderate quality (Supplementary Table 2).

Discussion

Summary of findings

Both healthy dietary pattern and physical activity were consistently associated with reduced risk across the NCD categories,^{11,75,77,90,93,94,98} and a comprehensive body of evidence substantiated these findings. Smoking and air pollution were also associated with increased risk of incident NCDs,^{11,14,77–79,82,87,89,92,95} and to a lesser extent, so were high blood pressure and obesity.^{11,77,81,84,85,96} The evidence for depression and high cholesterol was suggestive of increased risk for the cardiovascular rather than the cancer outcomes,^{11,77,80,86,88} with the weakest evidence for alcohol as a common risk factor.^{11,76,91,97,99}

Strengths and limitations

The strengths of our review include the use of a pragmatic high-level but systematic overview of reviews strategy. This has allowed us to deliver a broad evidence-based overview, drawing together information on the relationships between prevalent NCD and common risk factors. This has been further facilitated by the recent rise in published overview and single systematic reviews examining single disease or single risk factors. The global ageing population, rising prevalence of concomitant lifestyle and NCD risk factors and disease also make research across common NCDs both timely and important. Our review is an essential step towards a greater public health understanding of the interacting relationships driving NCDs. It has allowed us to document and highlight the overlapping risk factors and will help direct future work in this area.

Limitations inherent in drawing together existing reviews, and in particular overview reviews, inevitably include the risk of propagating existing bias. This may include selection bias driven by the inclusion of particular participants in cohort studies, inclusion of particular cohort studies or cohort study results in systematic reviews and meta-analyses and the inclusion of particular reviews in overview reviews. As in any review, further bias may come from drawing together varied reporting of results, analytical approaches, assessment of risk factor exposure, accounting for confounders and the possibility of reporting error. The AMSTAR-2 assessment tool, although the most appropriate, is not designed to assess overview reviews and, in part due to its rigour, is likely to assess anything other than very recent reviews as lower quality. Bias in overview reviews may also come from the age of the constituent studies with older studies potentially included in greater numbers of meta-analyses, and possibly also of lower quality. Our methods too, while systematized, may be a source of bias. Overall our review process was pragmatic and rigorous but inevitably open to bias. Taking a top-level focus and using existing reviews and meta-analyses meant that we were able to review a wide area but were unable to statistically synthesize the evidence or revisit the original cohort studies or participant level data where (1) evidence although present, might feature only to a lesser degree, for example for AD and hypertension, or (2) where risk relationships are long established and meta-analyses may never have been performed, for example smoking and CHD. Caution also needs to be applied where constituent studies were themselves rated poorly in terms of risk of bias. Furthermore, in taking a pragmatic approach to the classification of NCDs we may have missed some subtleties in the varied cancer diagnoses and inadvertently introduced a false level of certainty with regard to dementia type where overlapping pathology, rather than definitive diagnosis, is acknowledged as the most common occurrence.¹⁰² Finally, for dementia at least, there is some evidence that age of exposure to the different risk factors may moderate their impact^103–105 and we were unable to take this into account. Nevertheless, our findings are consistent in showing the complexity and overlap of the relationships in this area.

Implications and research recommendations

Although our results suggest that exposure to individual risk factors may act to concurrently raise the risk of more than one NCD we did not find sufficient evidence to allow us to extract or infer the strength of these relationships. Furthermore, we know that risk factors often co-occur¹⁰⁶ and, at least for dementia, there is a dose response with greater numbers of risk factors conferring higher levels of risk.¹⁴ In addition, neither the risk factors nor the outcomes are independent. For example, both stroke and diabetes increase risk of dementia and obesity raises risk of diabetes, high blood pressure and dementia.^101,107 In fact, it is more likely that the true relationships are best represented as a web of influence with relationships within and between both risk factors and outcomes. These putative relationships now need to be clarified using high quality longitudinal participant level data. Suitable datasets should represent relevant global populations and have sufficiently long follow up to evaluate confounded and competing relationships and to allow sufficient confidence about inferred causal relationships, thereby avoiding issues such as reverse causality.¹⁰⁰ Further risk factors and outcomes may exist beyond those examined here and these too need to be investigated.

Our review also noted age as a risk factor common to each of the NCDs. Although typically considered a nonmodifiable risk factor, the risk it contributes varies between individuals. Variability in the risk of death for people of the same age was labelled as ‘frailty’ in 1979.¹⁰⁸ The concept was later generalized to describe variability in the risk of an adverse outcome for people with the same degree of exposure. It is commonly implemented as a term that accounts for unobserved random effect in proportional hazards models. As reviewed elsewhere, frailty is also operationalized as a clinical syndrome or as a state.¹⁰⁹ As noted there, in either guise, it is an important independent risk for common late-life illnesses, including heart disease, osteoporotic fracture and dementia. Recently, the degree of frailty was found to moderate the relationship between neuropathologically defined AD and its clinical expression as dementia. Inasmuch as some degree of frailty may be modifiable, then understanding its role in disease is important. Further, understanding what it is about ageing that makes it such a common risk factor may lead to interventions that can reduce the burden of age.¹¹⁰

Wider context and the next steps

In this overview, we have highlighted the likely overlap between risk factors for NCDs and called for further work to quantify the strength and direction of the relationships between risk factors and incident NCDs. In addition, given the likely complexity of the associations, we have also highlighted the need to evaluate the relationships between the risk factors themselves and between the disease states. This is timely. The changing prevalence of NCD around the world makes further understanding of these complex inter-relationships a priority. The WHO recorded the top two global causes of death in 2000 and 2016 as CHD and stroke, but by 2016, AD and other dementias and trachea bronchus and lung cancers were present. In wealthier countries in 2016, NCDs were even more strongly represented alongside CHD, stroke and DM in lower-middle- and low-income countries.¹⁸ Furthermore, research looking at population-attributable risk for established dementia risk factors reported the possibility of reducing dementia risk by up to 28% (taking account of overlaps between risk factors), with some of the biggest drivers of increased risk identified as physical inactivity and smoking.¹⁰⁶ This analysis now needs to be extended to incorporate wider NCDs. Once we have clarified the strength of the relationships in the web of influence between the risk factors and disease states our next step must be to extend this to include population-attributable risk, design and evaluation of informed and targeted NCD risk reduction intervention and eventually, economic impact. The main NCDs and their risk factors are connected and prevalent; prevention is vital, but resources inevitably limited. An interactive economic model, where we can explore and evaluate the impact of risk reduction strategies on multiple interacting disease states, would be an invaluable public health tool. Such a tool is currently conceptual but represents a goal towards which all interested parties should be working.

In our high-level overview of the epidemiology we demonstrate the interconnected and overlapping relationships between common risk factors and common NCDs. Gaining a greater understanding and taking greater account of these relationships will facilitate more appropriate and targeted risk reduction, and this should now be our goal.

Supplemental Material

TACD_Supplement__13_Aug_2019_Fig__PRISMA_update – Supplemental material for Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction

Supplemental material, TACD_Supplement__13_Aug_2019_Fig__PRISMA_update for Common risk factors for major noncommunicable disease, a systematic overview of reviews and commentary: the implied potential for targeted risk reduction by Ruth Peters, Nicole Ee, Jean Peters, Nigel Beckett, Andrew Booth, Kenneth Rockwood and Kaarin J. Anstey in Therapeutic Advances in Chronic Disease

Footnotes

Acknowledgements

The authors acknowledge funding from the Australian National Health and Medical Research Council (NHMRC), the NHMRC National Institute for Dementia Research and the NHMRC Dementia Collaborative Research Centre.

Funding

The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The authors are supported by funding from a variety of sources including the Australian National Health and Medical Research Centre but received no financial support directed specifically for the research, authorship, and/or publication of this article.

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

ORCID iD

Ruth Peters

Supplemental material

Supplemental material for this article is available online.

References

Wang

Naghavi

Allen

, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 2016; 388: 1459–1544.

Beaglehole

Bonita

Horton

, et al. Priority actions for the non-communicable disease crisis. Lancet 2011; 377: 1438–1447.

World Health Organization. World report on ageing and health. Geneva: World Health Organization, 2015.

World Health Organization. Dementia: a public health priority. Geneva: World Health Organization, 2012.

Skoog

Lernfelt

Landahl

, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347: 1141–1145.

Gustafson

Backman

Waern

, et al. Adiposity indicators and dementia over 32 years in Sweden. Neurology 2009; 73: 1559–1566.

Mielke

Zandi

Sjogren

, et al. High total cholesterol levels in late life associated with a reduced risk of dementia. Neurology 2005; 64: 1689–1695.

Forette

Seux

Staessen

, et al. Prevention of dementia in randomised double-blind placebo-controlled Systolic Hypertension in Europe (Syst-Eur) trial. Lancet 1998; 352: 1347–1351.

Valenzuela

Sachdev

Can cognitive exercise prevent the onset of dementia? Systematic review of randomized clinical trials with longitudinal follow-up. Am J Geriat Psychiat 2009; 17: 179–187.

10.

Peters

Beckett

Forette

, et al. Incident dementia and blood pressure lowering in the hypertension in the very elderly trial cognitive function assessment (HYVET-COG): a double-blind, placebo-controlled trial. Lancet Neurol 2008; 7: 683–689.

11.

Anstey

Eramudugolla

, et al. A systematic review of meta-analyses that evaluate risk factors for dementia to evaluate the quantity, quality and global representativeness of evidence. J Alzheimers Dis 2019; 70: S165–S186.

12.

Bellou

Belbasis

Tzoulaki

, et al. Systematic evaluation of the associations between environmental risk factors and dementia: an umbrella review of systematic reviews and meta-analyses. Alzheimers Dement 2017; 13: 406–418.

13.

Tan

Wang

, et al. Meta-analysis of modifiable risk factors for Alzheimer’s disease. J Neurol Neurosurg Psychiatry 2015; 86: 1299–1306.

14.

Peters

Booth

Rockwood

, et al. Combining modifiable risk factors and risk of dementia: a systematic review and meta-analysis. BMJ Open 2019; 9: e022846.

15.

Rosenberg

Ngandu

Rusanen

, et al. Multidomain lifestyle intervention benefits a large elderly population at risk for cognitive decline and dementia regardless of baseline characteristics: the FINGER trial. Alzheimers Dement 2018; 14: 263–270.

16.

van Charante

EPM

Richard

Eurelings

, et al. Effectiveness of a 6-year multidomain vascular care intervention to prevent dementia (preDIVA): a cluster-randomised controlled trial. 2016; 388: 797–805.

17.

Vellas

Carrie

Gillette-Guyonnet

, et al. MAPT study: a multidomain approach for preventing Alzheimer’s disease: design and baseline data. J Prev Alzheimers Dis 2014; 1: 13–22.

18.

World Health Organization. The top 10 causes of death, https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death (2019, accessed 21 May 2019).

19.

World Health Organization. Risk Reduction of Cognitive Decline and Dementia: WHO Guidelines. Geneva: World Health Organization, 2019.

20.

Meschia

Bushnell

Boden-Albala

, et al. Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014; 45: 3754–3832.

21.

Bayo

Molina

Perez

, et al. SEOM clinical guidelines to primary prevention of cancer (2018). Clin Transl Oncol 2019; 21: 106–113.

22.

Arnett

Blumenthal

Albert

, et al. 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease. J Am Call Cardiol. 2019: 26029. DOI: 10.1016/j.jacc.2019.03.010.

23.

World Health Organization. Global Health Observatory (GHO) data: risk factors, https://www.who.int/gho/ncd/risk_factors/en/ (2019, accessed 21 May 2019).

24.

Grant

Booth

A typology of reviews: an analysis of 14 review types and associated methodologies. Health Info Libr J 2009; 26: 91–108.

25.

Moher

Shamseer

Clarke

, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 2015; 4: 1.

26.

World Health Organization. WHO handbook for guideline development, 2nd ed. Geneva: World Health Organization, 2014.

27.

Shea

Reeves

Wells

, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ 2017; 358: j4008.

28.

Al Tunaiji

Davis

Mackey

, et al. Population attributable fraction of type 2 diabetes due to physical inactivity in adults: a systematic review. BMC Public Health 2014; 14: 469.

29.

Albuquerque

Baltar

Marchioni

DM.

Breast cancer and dietary patterns: a systematic review. Nutr Rev 2014; 72: 1–17.

30.

Alhazmi

Stojanovski

McEvoy

, et al. The association between dietary patterns and type 2 diabetes: a systematic review and meta-analysis of cohort studies. J Hum Nutr Diet 2014; 27: 251–260.

31.

Ariesen

Claus

Rinkel

, et al. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003; 34: 2060–2065.

32.

Balti

Echouffo-Tcheugui

Yako

, et al. Air pollution and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetes Res Clin Pract 2014; 106: 161–172.

33.

Bell

Kivimaki

Hamer

Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies. Obes Rev 2014; 15: 504–515.

34.

Blondell

Hammersley-Mather

Veerman

JL.

Does physical activity prevent cognitive decline and dementia? A systematic review and meta-analysis of longitudinal studies. BMC Public Health 2014; 14: 510.

35.

Di Marco

Marzo

Munoz-Ruiz

, et al. Modifiable lifestyle factors in dementia: a systematic review of longitudinal observational cohort studies. J Alzheimers Dis 2014; 42: 119–135.

36.

Dinu

Pagliai

Casini

, et al. Mediterranean diet and multiple health outcomes: an umbrella review of meta-analyses of observational studies and randomised trials. Eur J Clin Nutr 2018; 72: 30–43.

37.

Esposito

Chiodini

Maiorino

, et al. Which diet for prevention of type 2 diabetes? A meta-analysis of prospective studies. Endocrine 2014; 47: 107–116.

38.

Feigin

Rinkel

Lawes

, et al. Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies. Stroke 2005; 36: 2773–2780.

39.

Goncalves

Dantas Florencio

Maisonnette de Atayde Silva

, et al. Effects of physical activity on breast cancer prevention: a systematic review. J Phys Act Health 2014; 11: 445–454.

40.

Grosso

Mistretta

Frigiola

, et al. Mediterranean diet and cardiovascular risk factors: a systematic review. Crit Rev Food Sci Nutr 2014; 54: 593–610.

41.

InterAct

Spijkerman

van der

, et al. Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations. Diabetes Care 2014; 37: 3164–3171.

42.

Janghorbani

Momeni

Mansourian

Systematic review and metaanalysis of air pollution exposure and risk of diabetes. Eur J Epidemiol 2014; 29: 231–242.

43.

Koloverou

Esposito

Giugliano

, et al. The effect of Mediterranean diet on the development of type 2 diabetes mellitus: a meta-analysis of 10 prospective studies and 136,846 participants. Metabolism 2014; 63: 903–911.

44.

Kontogianni

Panagiotakos

DB.

Dietary patterns and stroke: a systematic review and re-meta-analysis. Maturitas 2014; 79: 41–47.

45.

Yang

Zhang

, et al. Systematic review and meta-analysis suggest that dietary cholesterol intake increases risk of breast cancer. Nutr Res 2016; 36: 627–635.

46.

Lin

Liu

, et al. Dietary cholesterol intake and risk of lung cancer: a meta-analysis. Nutrients 2018; 10: 185.

47.

Mackay

Pell

JP.

Meta-analysis of the association between cigarette smoking and peripheral arterial disease. Heart 2014; 100: 414–423.

48.

McEvoy

Cardwell

Woodside

, et al. A posteriori dietary patterns are related to risk of type 2 diabetes: findings from a systematic review and meta-analysis. J Acad Nutr Diet 2014; 114: 1759–1775.e4.

49.

Meng

Wang

, et al. Midlife vascular risk factors and the risk of Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 42: 1295–1310.

50.

Mente

de Koning

Shannon

, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med 2009; 169: 659–669.

51.

Milton

Macniven

Bauman

Review of the epidemiological evidence for physical activity and health from low- and middle-income countries. Glob Public Health 2014; 9: 369–381.

52.

Monninkhof

Elias

Vlems

, et al. Physical activity and breast cancer: a systematic review. Epidemiology 2007; 18: 137–157.

53.

Mustafic

Jabre

Caussin

, et al. Main air pollutants and myocardial infarction: a systematic review and meta-analysis. JAMA 2012; 307: 713–721.

54.

Namiranian

Moradi-Lakeh

Razavi-Ratki

, et al. Risk factors of breast cancer in the Eastern Mediterranean region: a systematic review and meta-analysis. Asian Pac J Cancer Prev 2014; 15: 9535–9541.

55.

Otaegui-Arrazola

Amiano

Elbusto

, et al. Diet, cognition, and Alzheimer’s disease: food for thought. Eur J Nutr 2014; 53: 1–23.

56.

Park

Wang

Ambient air pollution and type 2 diabetes: a systematic review of epidemiologic research. Curr Environ Health Rep 2014; 1: 275–286.

57.

Renn

Feliciano

Segal

DL.

The bidirectional relationship of depression and diabetes: a systematic review. Clin Psychol Rev 2011; 31: 1239–1246.

58.

Roerecke

Rehm

Alcohol consumption, drinking patterns, and ischemic heart disease: a narrative review of meta-analyses and a systematic review and meta-analysis of the impact of heavy drinking occasions on risk for moderate drinkers. BMC Med 2014; 12: 182.

59.

Rugulies

Depression as a predictor for coronary heart disease - a review and meta-analysis. Am J Prev Med 2002; 23: 51–61.

60.

Schwingshackl

Hoffmann

Adherence to Mediterranean diet and risk of cancer: a systematic review and meta-analysis of observational studies. Int J Cancer 2014; 135: 1884–1897.

61.

Shah

Langrish

Nair

, et al. Global association of air pollution and heart failure: a systematic review and meta-analysis. Lancet 2013; 382: 1039–1048.

62.

Shah

Lee

McAllister

, et al. Short term exposure to air pollution and stroke: systematic review and meta-analysis. BMJ 2015; 350: h1295.

63.

Shanmugalingam

Crawley

Bosco

, et al. Obesity and cancer: the role of vitamin D. BMC Cancer 2014; 14: 712.

64.

Shi

Wang

, et al. Household physical activity and cancer risk: a systematic review and dose-response meta-analysis of epidemiological studies. Sci Rep 2015; 5: 14901.

65.

Singh

Parsaik

Mielke

, et al. Association of Mediterranean diet with mild cognitive impairment and Alzheimer’s disease: a systematic review and meta-analysis. J Alzheimers Dis 2014; 39: 271–282.

66.

Stafoggia

Cesaroni

Peters

, et al. Long-term exposure to ambient air pollution and incidence of cerebrovascular events: results from 11 European cohorts within the ESCAPE project. Environ Health Perspect 2014; 122: 919–925.

67.

Sun

Liu

Wang

, et al. Passive smoke exposure and risk of diabetes: a meta-analysis of prospective studies. Endocrine 2014; 47: 421–427.

68.

Tajima

Kodama

Hirata

, et al. High cholesterol intake is associated with elevated risk of type 2 diabetes mellitus - a meta-analysis. Clin Nutr 2014; 33: 946–950.

69.

Touvier

Fassier

His

, et al. Cholesterol and breast cancer risk: a systematic review and meta-analysis of prospective studies. Br J Nutr 2015; 114: 347–357.

70.

Wang

Dong

, et al. Cholesterol levels and risk of hemorrhagic stroke: a systematic review and meta-analysis. Stroke 2013; 44: 1833–1839.

71.

Wang

Eliot

Wellenius

GA.

Short-term changes in ambient particulate matter and risk of stroke: a systematic review and meta-analysis. J Am Heart Assoc 2014; 3: e000983.

72.

Xia

Chen

, et al. Body mass index and risk of breast cancer: a nonlinear dose-response meta-analysis of prospective studies. Sci Rep 2014; 4: 7480.

73.

Yang

Wang

Deng

, et al. An evidence-based appraisal of global association between air pollution and risk of stroke. Int J Cardiol 2014; 175: 307–313.

74.

Zhu

Wang

, et al. The association between passive smoking and type 2 diabetes: a meta-analysis. Asia-Pac J Public He 2014; 26: 226–237.

75.

Rezende

LFM

Markozannes

, et al. Physical activity and cancer: an umbrella review of the literature including 22 major anatomical sites and 770 000 cancer cases. Br J Sports Med 2018; 52: 826–833.

76.

Bagnardi

Rota

Botteri

, et al. Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis. Br J Cancer 2015; 112: 580–593.

77.

Bellou

Belbasis

Tzoulaki

, et al. Risk factors for type 2 diabetes mellitus: an exposure-wide umbrella review of meta-analyses. PLoS ONE 2018; 13: e0194127.

78.

Botteri

Iodice

Bagnardi

, et al. Smoking and colorectal cancer: a meta-analysis. J Am Med Assoc 2008; 300: 2765–2778.

79.

Cesaroni

Forastiere

Stafoggia

, et al. Long term exposure to ambient air pollution and incidence of acute coronary events: prospective cohort study and meta-analysis in 11 European cohorts from the ESCAPE Project. BMJ 2014; 348: f7412.

80.

Gan

Gong

Tong

, et al. Depression and the risk of coronary heart disease: a meta-analysis of prospective cohort studies. BMC Psychiatry 2014; 14: 371.

81.

Global Burden of Metabolic Risk Factors for Chronic Diseases Collaboration, Lu

Hajifathalian

Ezzati

, et al. Metabolic mediators of the effects of body mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants. Lancet 2014; 383: 970–983.

82.

Hamra

Guha

Cohen

, et al. Outdoor particulate matter exposure and lung cancer: a systematic review and meta-analysis. Environ Health Perspect 2014; 122: 906–911.

83.

Han

Guo

Shi

, et al. Hypertension and breast cancer risk: a systematic review and meta-analysis. Sci Rep 2017; 7: 44877.

84.

Huang

Cai

, et al. Prehypertension and the risk of stroke: a meta-analysis. Neurology 2014; 82: 1153–1161.

85.

Kyrgiou

Kalliala

Markozannes

, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 2017; 356: j477.

86.

Lindbohm

Kaprio

Korja

Cholesterol as a risk factor for subarachnoid hemorrhage: a systematic review. PLoS ONE 2016; 11: e0152568.

87.

O’Keeffe

Taylor

Huxley

, et al. Smoking as a risk factor for lung cancer in women and men: a systematic review and meta-analysis. BMJ Open 2018; 8: e021611.

88.

Peters

Singhateh

Mackay

, et al. Total cholesterol as a risk factor for coronary heart disease and stroke in women compared with men: a systematic review and meta-analysis. Atherosclerosis 2016; 248: 123–131.

89.

Peters

Huxley

Woodward

Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. Stroke 2013; 44: 2821–2828.

90.

Psaltopoulou

Sergentanis

Panagiotakos

, et al. Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis. Ann Neurol 2013; 74: 580–591.

91.

Roerecke

Rehm

Chronic heavy drinking and ischaemic heart disease: a systematic review and meta-analysis. Open Heart 2014; 1: e000135.

92.

Scheers

Jacobs

Casas

, et al. Long-term exposure to particulate matter air pollution is a risk factor for stroke: meta-analytical evidence. Stroke 2015; 46: 3058–3066.

93.

Schwingshackl

Schwedhelm

Galbete

, et al. Adherence to Mediterranean diet and risk of cancer: an updated systematic review and meta-analysis. Nutrients 2017; 9: E1063.

94.

Wahid

Manek

Nichols

, et al. Quantifying the association between physical activity and cardiovascular disease and diabetes: a systematic review and meta-analysis. J Am Heart Assoc 2016; 5: e002495.

95.

Wang

Zhang

, et al. Smoking increases risks of all-cause and breast cancer specific mortality in breast cancer individuals: a dose-response meta-analysis of prospective cohort studies involving 39725 breast cancer cases. Oncotarget 2016; 7: 83134–83147.

96.

Wei

George

Chang

, et al. Assessing sex differences in the risk of cardiovascular disease and mortality per increment in systolic blood pressure: a systematic review and meta-analysis of follow-up studies in the United States. PLoS ONE 2017; 12: e0170218.

97.

Zhang

Qin

Chen

, et al. Alcohol intake and risk of stroke: a dose-response meta-analysis of prospective studies. Int J Cardiol 2014; 174: 669–677.

98.

Galbete

Schwingshackl

Schwedhelm

, et al. Evaluating Mediterranean diet and risk of chronic disease in cohort studies: an umbrella review of meta-analyses. Eur J Epidemiol 2018; 33: 909–931.

99.

Turati

Galeone

Rota

, et al. Alcohol and liver cancer: a systematic review and meta-analysis of prospective studies. Ann Oncol 2014; 25: 1526–1535.

100.

Peters

Booth

, et al. Trajectory of blood pressure, body mass index, cholesterol and incident dementia. A systematic review. Br J Psychiatry 2019: 1–13. DOI: 10.1192/bjp.2019.156.

101.

Prince

Albanese

Guerchet

, et al. World Alzheimer Report 2014. Dementia and risk reduction. Alzheimer’s Disease International, https://www.alz.co.uk/research/world-report-2014 (accessed 25 September 2019).

102.

Attems

Jellinger

KA.

The overlap between vascular disease and Alzheimer’s disease–lessons from pathology. BMC Med 2014; 12: 206.

103.

Anstey

Cherbuin

Budge

, et al. Body mass index in midlife and late-life as a risk factor for dementia: a meta-analysis of prospective studies. 2011; 12: e426–e37.

104.

Whitmer

Sidney

Selby

, et al. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology 2005; 64: 277–281.

105.

Barnes

Yaffe

Byers

, et al. Midlife vs late-life depressive symptoms and risk of dementia: differential effects for Alzheimer disease and vascular dementia. Arch Gen Psychiatry 2012; 69: 493–498.

106.

Norton

Matthews

Barnes

, et al. Potential for primary prevention of Alzheimer’s disease: an analysis of population-based data. Lancet Neurol 2014; 13: 788–794.

107.

World Health Organisation. Global status report on noncommunicable diseases 2014. Geneva: World Health Organisation, 2014.

108.

Vaupel

Manton

Stallard

The impact of heterogeneity in individual frailty on the dynamics of mortality. Demography 1979; 16: 439–454.

109.

Rockwood

Howlett

SE.

Age-related deficit accumulation and the diseases of ageing. Mech Ageing Dev 2019; 180: 107–116.

110.

Justice

Nambiar

Tchkonia

, et al. Senolytics in idiopathic pulmonary fibrosis: results from a first-in-human, open-label, pilot study. EBioMedicine 2019; 40: 554–563.

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.64 MB